SD

Shubhashree Das

Active Director Director DIN 09153161
DIN 09153161 First appointment Apr 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Shubhashree Das

Data last updated:

Shubhashree Das is a Director at Ymad Pharma Private Limited (since 2021). The company operates in Chemicals. Ymad Pharma Private Limited reported revenue of ₹11.4 Lakh (FY 2022).

DIN 09153161
Primary Designation Director
Industry Chemicals
First Appointment 21 Apr 2021
Oldest Company Age 5 yrs
Largest company Ymad Pharma Private Limited · ₹11.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ymad Pharma Private Limited U24299OR2021PTC036282
Director21 Apr 20212021₹11.4 Lakh (FY 2022)Active

Board colleagues of Shubhashree Das

Directorship timeline

Open interactive timeline →
Ymad Pharma Private Limited
Premium access

Shareholding and investment profile for Shubhashree Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhashree Das

Shubhashree Das currently holds 1 directorship: Ymad Pharma Private Limited (Director, since 21 Apr 2021, revenue ₹11.4 Lakh (FY 2022)).

Shubhashree Das was first appointed on 21 Apr 2021 as Director at Ymad Pharma Private Limited.

The current boards of Shubhashree Das's companies include Kalpana Panda (Ymad Pharma Private Limited), Rashmi Ranjan Panda (Ymad Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available